CPG
CLB icon

Cornerstone Planning Group’s Core Laboratories CLB Stock Holding History

Cornerstone Planning Group’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-49
Closed -$526 – 1711
2025
Q2 		$526 Buy
+49
New +$581 ﹤0.01% 1287
2025
Q1 		– Sell
-144
Closed -$2.74K – 1583
2024
Q4 		$2.74K Sell
144
-52
-27% -$1K ﹤0.01% 710
2024
Q3 		$3.82K Hold
196
– – ﹤0.01% 634
2024
Q2 		$4.1K Buy
196
+52
+36% +$920 ﹤0.01% 617
2024
Q1 		$2.29K Buy
+144
New +$2.27K ﹤0.01% 639

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Cornerstone Planning Group's CLB Position: Q3 2025 in Review

Cornerstone Planning Group sold out of Core Laboratories (CLB) in Q3 2025, closing a stake of 49 shares — an estimated $526 sold.

Cornerstone Planning Group first reported a position in CLB in Q1 2024 and held it in 5 quarters. The position peaked at $4.1K in Q2 2024. 190 funds tracked by Wall St. Rank hold CLB as of Q3 2025.

  • Cornerstone Planning Group reported no remaining Core Laboratories position as of Q3 2025 after selling out during the quarter.
  • Cornerstone Planning Group sold 49 Core Laboratories shares in Q3 2025, an estimated $526.
  • Cornerstone Planning Group first reported a position in Core Laboratories in Q1 2024 and held it in 5 quarters.
  • Cornerstone Planning Group's Core Laboratories position peaked at $4.1K in Q2 2024.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2025.

Based on Cornerstone Planning Group's 13F filing for Q3 2025, filed 4 Nov 2025.